<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37223650</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-4976</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Comprehensive psychoneuroendocrinology</Title><ISOAbbreviation>Compr Psychoneuroendocrinol</ISOAbbreviation></Journal><ArticleTitle>Inflammatory and mental health sequelae of COVID-19.</ArticleTitle><Pagination><StartPage>100186</StartPage><MedlinePgn>100186</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100186</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cpnec.2023.100186</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has caused significant negative consequences to mental health. Increased inflammatory factors and neuropsychiatric symptoms, such as cognitive impairment ("brain fog"), depression, and anxiety are associated with long COVID [post-acute sequelae of SARS-CoV-2 infection (PASC), termed neuro-PASC]. The present study sought to examine the role of inflammatory factors as predictors of neuropsychiatric symptom severity in the context of COVID-19. Adults (n&#xa0;=&#xa0;52) who tested negative or positive for COVID-19 were asked to complete self-report questionnaires and to provide blood samples for multiplex immunoassays. Participants who tested negative for COVID-19 were assessed at baseline and at a follow-up study visit (&#x223c;4 weeks later). Individuals without COVID-19 reported significantly lower PHQ-4 scores at the follow-up visit, as compared to baseline (<i>p</i>&#xa0;=&#xa0;0.03; 95% CI-1.67 to -0.084). Individuals who tested positive for COVID-19 and experienced neuro-PASC had PHQ-4 scores in the moderate range. The majority of people with neuro-PASC reported experiencing brain fog (70% vs. 30%). Those with more severe COVID-19 had significantly higher PHQ-4 scores, as compared to those with mild disease (<i>p</i>&#xa0;=&#xa0;0.008; 95% CI 1.32 to 7.97). Changes in neuropsychiatric symptom severity were accompanied by alterations in immune factors, particularly monokine induced by gamma interferon (IFN-&#x3b3;) (MIG, a. k.a. CXCL9). These findings add to the growing evidence supporting the usefulness of circulating MIG levels as a biomarker reflecting IFN-&#x3b3; production, which is important because individuals with neuro-PASC have elevated IFN-&#x3b3; responses to internal SARS-CoV-2 proteins.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Loftis</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Research &amp; Development Service, VA Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Psychology PhD Program, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Behavioral Neuroscience, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Firsick</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Research &amp; Development Service, VA Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirley</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Research &amp; Development Service, VA Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Psychology PhD Program, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adkins</LastName><ForeName>James L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Research Service, Department of Veterans Affairs, James H. Quillen Veterans Affairs Medical Center, Johnson City, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence in Inflammation, Infectious Diseases and Immunity, East Tennessee State University, 1276 Gilbreath Drive, Box 70300, Johnson City, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le-Cook</LastName><ForeName>Anh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research &amp; Development Service, VA Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sano</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Research &amp; Development Service, VA Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hudson</LastName><ForeName>Rebekah</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Research &amp; Development Service, VA Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moorman</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Service, Department of Veterans Affairs, James H. Quillen Veterans Affairs Medical Center, Johnson City, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence in Inflammation, Infectious Diseases and Immunity, East Tennessee State University, 1276 Gilbreath Drive, Box 70300, Johnson City, TN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX002061</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX005428</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Compr Psychoneuroendocrinol</MedlineTA><NlmUniqueID>101774169</NlmUniqueID><ISSNLinking>2666-4976</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anxiety</Keyword><Keyword MajorTopicYN="N">Chemokine</Keyword><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Cytokine</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>11</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37223650</ArticleId><ArticleId IdType="pmc">PMC10191701</ArticleId><ArticleId IdType="doi">10.1016/j.cpnec.2023.100186</ArticleId><ArticleId IdType="pii">S2666-4976(23)00020-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Santomauro D.F. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet (London, England) 2021;398:1700&#x2013;1712. doi: 10.1016/S0140-6736(21)02143-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02143-7</ArticleId><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews J.L., Li M., Minihan S., Songco A., Fox E., Ladouceur C.D., Mewton L., Moulds M., Pfeifer J.H., Van Harmelen A.-L., Schweizer S. The effect of intolerance of uncertainty on anxiety and depression, and their symptom networks, during the COVID-19 pandemic. BMC Psychiatr. 2023;23:261. doi: 10.1186/s12888-023-04734-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-023-04734-8</ArticleId><ArticleId IdType="pmc">PMC10109227</ArticleId><ArticleId IdType="pubmed">37069541</ArticleId></ArticleIdList></Reference><Reference><Citation>Brailovskaia J., Margraf J., Ceccatelli S., Cosci F. The relationship among psychological distress, well-being and excessive social media use during the outbreak of Covid-19: a longitudinal investigation. Clin. Psychol. Psychother. 2023 doi: 10.1002/cpp.2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpp.2853</ArticleId><ArticleId IdType="pubmed">37056167</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed B.A., Ismael S.K., Amin R.M., Mahmud N.M., Al-Banna D.A., Shabila N.P. Prevalence and determinants of anxiety and stress in the general population during COVID-19 pandemic in Iraq: a cross-sectional study. PLoS One. 2023;18 doi: 10.1371/journal.pone.0283260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0283260</ArticleId><ArticleId IdType="pmc">PMC10096275</ArticleId><ArticleId IdType="pubmed">37043487</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksunger N., Vernot C., Littman R., Voors M., Meriggi N.F., Abajobir A., Beber B., Dai K., Egger D., Islam A., Kelly J., Kharel A., Matabaro A., Moya A., Mwachofi P., Nekesa C., Ochieng E., Rahman T., Scacco A., van Dalen Y., Walker M., Janssens W., Mobarak A.M. COVID-19 and mental health in 8 low- and middle-income countries: a prospective cohort study. PLoS Med. 2023;20 doi: 10.1371/journal.pmed.1004081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004081</ArticleId><ArticleId IdType="pmc">PMC10079130</ArticleId><ArticleId IdType="pubmed">37023021</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F., Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., Choueiri T.K., Uriel N., Ausiello J.C., Accili D., Freedberg D.E., Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan E.Y. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto A.A., Carroll L.S., Nar V., Varatharaj A., Galea I. CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19. Neurol Neuroimmunol Neuroinflamm. 2020 doi: 10.1212/NXI.0000000000000813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000813</ArticleId><ArticleId IdType="pmc">PMC7309522</ArticleId><ArticleId IdType="pubmed">32522768</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer E.A., Kohn J.N., Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav. Immun. 2020 doi: 10.1016/j.bbi.2020.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., Chinchilli V.M. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw. Open. 2021;4 doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Yang D., Lewis A., Patel P., Medicherla C., Arena V., Fang T., Andino A., Snyder T., Madhavan M., Gratch D., Fuchs B., Dessy A., Canizares M., Jauregui R., Thomas B., Bauman K., Olivera A., Bhagat D., Sonson M., Park G., Stainman R., Sunwoo B., Talmasov D., Tamimi M., Zhu Y., Rosenthal J., Dygert L., Ristic M., Ishii H., Valdes E., Omari M., Gurin L., Huang J., Czeisler B.M., Kahn D.E., Zhou T., Lin J., Lord A.S., Melmed K., Meropol S., Troxel A.B., Petkova E., Wisniewski T., Balcer L., Morrison C., Yaghi S., Galetta S. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J. Neurol. Sci. 2021;426 doi: 10.1016/j.jns.2021.117486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117486</ArticleId><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., G&#xf3;mez-Mayordomo V., de-la-Llave-Rinc&#xf3;n A.I., Palacios-Ce&#xf1;a M., Rodr&#xed;guez-Jim&#xe9;nez J., Florencio L.L., Velasco-Arribas M., Fuensalida-Novo S., Cigar&#xe1;n-M&#xe9;ndez M., Ambite-Quesada S., Guijarro C., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Ortega-Santiago R., Elvira-Mart&#xed;nez C.M., Molina-Trigueros L.J., Torres-Macho J., Sebasti&#xe1;n-Viana T., Canto-Diez M.G., Hern&#xe1;ndez-Barrera V., Palacios-Ce&#xf1;a D. Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: a multicenter study. J. Infect. 2021 doi: 10.1016/j.jinf.2021.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.06.022</ArticleId><ArticleId IdType="pmc">PMC8236125</ArticleId><ArticleId IdType="pubmed">34192525</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yang W., Chen F., Cui L. COVID-19 and cognitive impairment: neuroinvasive and blood&#x2012;brain barrier dysfunction. J. Neuroinflammation. 2022;19:222. doi: 10.1186/s12974-022-02579-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02579-8</ArticleId><ArticleId IdType="pmc">PMC9450840</ArticleId><ArticleId IdType="pubmed">36071466</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan K., Premi E., Pilotto A., Cristillo V., Benussi A., Libri I., Giunta M., Bockholt H.J., Liu J., Campora R., Pezzini A., Gasparotti R., Magoni M., Padovani A., Calhoun V.D. Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19. Neurobiol. Stress. 2021;14 doi: 10.1016/j.ynstr.2021.100326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ynstr.2021.100326</ArticleId><ArticleId IdType="pmc">PMC8041745</ArticleId><ArticleId IdType="pubmed">33869679</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xe4;ufer C., Schreiber C.S., Hartke A.-S., Denden I., Stanelle-Bertram S., Beck S., Kouassi N.M., Beythien G., Becker K., Schreiner T., Schaumburg B., Beineke A., Baumg&#xe4;rtner W., Gabriel G., Richter F. Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine. 2022;79 doi: 10.1016/j.ebiom.2022.103999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103999</ArticleId><ArticleId IdType="pmc">PMC9013202</ArticleId><ArticleId IdType="pubmed">35439679</ArticleId></ArticleIdList></Reference><Reference><Citation>Torices S., Motta C.S., da Rosa B.G., Marcos A.C., Alvarez-Rosa L., Siqueira M., Moreno-Rodriguez T., Matos A., Caetano B., Martins J., Gladulich L., Loiola E., Bagshaw O.R., Stuart J.A., Siqueira M.M., Stipursky J., Toborek M., Adesse D. SARS-CoV-2 infection of human brain microvascular endothelial cells leads to inflammatory activation through NF-&#x3ba;B non-canonical pathway and mitochondrial remodeling. bioRxiv Prepr. Serv. Biol. 2022 doi: 10.1101/2022.06.16.496324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.16.496324</ArticleId><ArticleId IdType="pmc">PMC10056985</ArticleId><ArticleId IdType="pubmed">36992454</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadman M. Lasting impact of infection extends to the brain. Science. 2022 doi: 10.1126/science.ada1334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.ada1334</ArticleId><ArticleId IdType="pubmed">35175790</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Rodr&#xed;uez-Jim&#xe9;nez J., Palacios-Ce&#xf1;a M., Velasco-Arribas M., Guijarro C., de-la-Llave-Rinc&#xf3;n A.I., Fuensalida-Novo S., Elvira-Mart&#xed;nez C.M., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Florencio L.L., Ortega-Santiago R., Molina-Trigueros L.J., Sebasti&#xe1;n-Viana T., Torres-Macho J., Canto-Diez G., Plaza-Canteli S., Cigar&#xe1;n-M&#xe9;ndez M., Ambite-Quesada S., Hern&#xe1;ndez-Barrera V., Arias-Bur&#xed;a J.L., Arendt-Nielsen L. Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: a multicenter study. J. Infect. 2021 doi: 10.1016/j.jinf.2021.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.04.036</ArticleId><ArticleId IdType="pmc">PMC8110627</ArticleId><ArticleId IdType="pubmed">33984399</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ. 2022;376 doi: 10.1136/bmj-2021-068993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022 doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., Zandi M.S., Lewis G., David A.S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The lancet. Psychiatry. 2020;7:611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Camacho-Arroyo I., Flores-Ramos M., Mancilla-Herrera I., Cruz F.M.C., Hern&#xe1;ndez-Ruiz J., Diaz G.P., Labonne B.F., Del Pilar Meza-Rodr&#xed;guez M., Gelman P.L. Chemokine profile in women with moderate to severe anxiety and depression during pregnancy. BMC Pregnancy Childbirth. 2021;21:807. doi: 10.1186/s12884-021-04225-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12884-021-04225-2</ArticleId><ArticleId IdType="pmc">PMC8642921</ArticleId><ArticleId IdType="pubmed">34863117</ArticleId></ArticleIdList></Reference><Reference><Citation>Loftis J.M., Huckans M., Ruimy S., Hinrichs D.J., Hauser P. Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci. Lett. 2008;430:264&#x2013;268. doi: 10.1016/j.neulet.2007.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2007.11.001</ArticleId><ArticleId IdType="pmc">PMC2342938</ArticleId><ArticleId IdType="pubmed">18063307</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin L.H., Langenecker S.A., Phan K.L., Keating S.M., Neigh G.N., Weber K.M., Maki P.M. Remitted depression and cognition in HIV: the role of cortisol and inflammation. Psychoneuroendocrinology. 2020;114 doi: 10.1016/j.psyneuen.2020.104609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2020.104609</ArticleId><ArticleId IdType="pmc">PMC7254879</ArticleId><ArticleId IdType="pubmed">32062371</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., B&#xfc;ttiker P., Weissenberger S., Martin A., Ptacek R., Kream R.M. Editorial: the pathogenesis of long-term neuropsychiatric COVID-19 and the role of microglia, mitochondria, and persistent neuroinflammation: a hypothesis. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2021 doi: 10.12659/MSM.933015.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.933015</ArticleId><ArticleId IdType="pmc">PMC8120907</ArticleId><ArticleId IdType="pubmed">34016942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R.L., Williams J.B.W., L&#xf6;we B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50:613&#x2013;621. doi: 10.1176/appi.psy.50.6.613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.50.6.613</ArticleId><ArticleId IdType="pubmed">19996233</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;we B., Wahl I., Rose M., Spitzer C., Glaesmer H., Wingenfeld K., Schneider A., Br&#xe4;hler E. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J. Affect. Disord. 2010;122:86&#x2013;95. doi: 10.1016/j.jad.2009.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2009.06.019</ArticleId><ArticleId IdType="pubmed">19616305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R.L., Williams J.B.W. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med. Care. 2003;41:1284&#x2013;1292. doi: 10.1097/01.MLR.0000093487.78664.3C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000093487.78664.3C</ArticleId><ArticleId IdType="pubmed">14583691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaccari B., Loftis J.M., Haywood T., Hubbard K., Clark J., Kelly U.A. Synchronous telehealth yoga and cognitive processing group therapies for women Veterans with posttraumatic stress disorder: a multisite randomized controlled trial adapted for COVID-19. Telemed. J. e-health off. J. Am. Telemed. Assoc. 2022 doi: 10.1089/tmj.2021.0612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/tmj.2021.0612</ArticleId><ArticleId IdType="pmc">PMC9519809</ArticleId><ArticleId IdType="pubmed">35357957</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">2081237</ArticleId></ArticleIdList></Reference><Reference><Citation>Saville D.J. Multiple comparison procedures: the practical solution. Am. Statistician. 1990;44:174&#x2013;180. doi: 10.2307/2684163.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2684163</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S., Banasik K., Pedersen O.B., Nissen J., Cantwell L., Schwinn M., Tulstrup M., Westergaard D., Ullum H., Brunak S., Tommerup N., Feenstra B., Geller F., Ostrowski S.R., Gr&#xf8;nb&#xe6;k K., Nielsen C.H., Nielsen S.D., Feldt-Rasmussen U. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci. Rep. 2021;11 doi: 10.1038/s41598-021-92045-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38 doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V., Stefanou M.-I., Demetriou M., Siafakas N., Makris M., Tsivgoulis G., Zoumpourlis V., Kympouropoulos S.P., Tsoporis J.N., Spandidos D.A., Smyrnis N., Rizos E. Long COVID and neuropsychiatric manifestations (Review) Exp. Ther. Med. 2022;23:363. doi: 10.3892/etm.2022.11290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanley J.E., Valenciano A.F., Timmons G., Miner A.E., Kakarla V., Rempe T., Yang J.H., Gooding A., Norman M.A., Banks S.J., Ritter M.L., Ellis R.J., Horton L., Graves J.S. Longitudinal evaluation of neurologic-post acute sequelae SARS-CoV-2 infection symptoms. Ann. Clin. Transl. Neurol. 2022;9:995&#x2013;1010. doi: 10.1002/acn3.51578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51578</ArticleId><ArticleId IdType="pmc">PMC9268882</ArticleId><ArticleId IdType="pubmed">35702954</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu D.P., Pradhan S.K., Sahoo D.P., Patra S., Singh A.K., Patro B.K. Fear and anxiety among COVID-19 Screening Clinic Beneficiaries of a tertiary care hospital of Eastern India. Asian J. Psychiatr. 2021;57 doi: 10.1016/j.ajp.2020.102543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2020.102543</ArticleId><ArticleId IdType="pmc">PMC7836328</ArticleId><ArticleId IdType="pubmed">33517132</ArticleId></ArticleIdList></Reference><Reference><Citation>Earnshaw V.A., Brousseau N.M., Hill E.C., Kalichman S.C., Eaton L.A., Fox A.B. Anticipated stigma, stereotypes, and COVID-19 testing. Stigma Heal. 2020;5:390&#x2013;393. doi: 10.1037/sah0000255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/sah0000255</ArticleId></ArticleIdList></Reference><Reference><Citation>Quagliato L.A., Nardi A.E. Cytokine profile in drug-na&#xef;ve panic disorder patients. Transl. Psychiatry. 2022;12:75. doi: 10.1038/s41398-022-01835-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-01835-y</ArticleId><ArticleId IdType="pmc">PMC8863842</ArticleId><ArticleId IdType="pubmed">35194013</ArticleId></ArticleIdList></Reference><Reference><Citation>Leff Gelman P., Mancilla-Herrera I., Flores-Ramos M., Saravia Takashima M.F., Cruz Coronel F.M., Cruz Fuentes C., P&#xe9;rez Molina A., Hern&#xe1;ndez-Ruiz J., Silva-Aguilera F.S., Farfan-Labonne B., Chinchilla-Ochoa D., Garza Morales S., Camacho-Arroyo I. The cytokine profile of women with severe anxiety and depression during pregnancy. BMC Psychiatr. 2019;19:104. doi: 10.1186/s12888-019-2087-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-019-2087-6</ArticleId><ArticleId IdType="pmc">PMC6446269</ArticleId><ArticleId IdType="pubmed">30943938</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Z., Ye G., Chen X., Pan M., Fu J., Fu T., Liu Q., Gao Z., Baldwin D.S., Hou R. Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder. J. Affect. Disord. 2018;225:593&#x2013;598. doi: 10.1016/j.jad.2017.08.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2017.08.082</ArticleId><ArticleId IdType="pubmed">28886500</ArticleId></ArticleIdList></Reference><Reference><Citation>Syed S.A., Beurel E., Loewenstein D.A., Lowell J.A., Craighead W.E., Dunlop B.W., Mayberg H.S., Dhabhar F., Dietrich W.D., Keane R.W., de Rivero Vaccari J.P., Nemeroff C.B. Defective inflammatory pathways in never-treated depressed patients are associated with poor treatment response. Neuron. 2018;99:914&#x2013;924. doi: 10.1016/j.neuron.2018.08.001. e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.08.001</ArticleId><ArticleId IdType="pmc">PMC6151182</ArticleId><ArticleId IdType="pubmed">30146307</ArticleId></ArticleIdList></Reference><Reference><Citation>Abers M.S., Delmonte O.M., Ricotta E.E., Fintzi J., Fink D.L., de Jesus A.A.A., Zarember K.A., Alehashemi S., Oikonomou V., Desai J.V., Canna S.W., Shakoory B., Dobbs K., Imberti L., Sottini A., Quiros-Roldan E., Castelli F., Rossi C., Brugnoni D., Biondi A., Bettini L.R., D'Angio&#x2019; M., Bonfanti P., Castagnoli R., Montagna D., Licari A., Marseglia G.L., Gliniewicz E.F., Shaw E., Kahle D.E., Rastegar A.T., Stack M., Myint-Hpu K., Levinson S.L., DiNubile M.J., Chertow D.W., Burbelo P.D., Cohen J.I., Calvo K.R., Tsang J.S., Su H.C., Gallin J.I., Kuhns D.B., Goldbach-Mansky R., Lionakis M.S., Notarangelo L.D. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI insight. 2021;6 doi: 10.1172/jci.insight.144455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.144455</ArticleId><ArticleId IdType="pmc">PMC7821609</ArticleId><ArticleId IdType="pubmed">33232303</ArticleId></ArticleIdList></Reference><Reference><Citation>Krysko O., Kondakova E., Vershinina O., Galova E., Blagonravova A., Gorshkova E., Bachert C., Ivanchenko M., Krysko D.V., Vedunova M. Artificial intelligence predicts severity of COVID-19 based on correlation of exaggerated monocyte activation, excessive organ damage and hyperinflammatory syndrome: a prospective clinical study. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.715072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.715072</ArticleId><ArticleId IdType="pmc">PMC8442605</ArticleId><ArticleId IdType="pubmed">34539644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Wong P., Klein J., Castro T.B.R., Silva J., Sundaram M., Ellingson M.K., Mao T., Oh J.E., Israelow B., Takahashi T., Tokuyama M., Lu P., Venkataraman A., Park A., Mohanty S., Wang H., Wyllie A.L., Vogels C.B.F., Earnest R., Lapidus S., Ott I.M., Moore A.J., Muenker M.C., Fournier J.B., Campbell M., Odio C.D., Casanovas-Massana A., Herbst R., Shaw A.C., Medzhitov R., Schulz W.L., Grubaugh N.D., Dela Cruz C., Farhadian S., Ko A.I., Omer S.B., Iwasaki A. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463&#x2013;469. doi: 10.1038/s41586-020-2588-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling L., Chen Z., Lui G., Wong C.K., Wong W.T., Ng R.W.Y., Tso E.Y.K., Fung K.S.C., Chan V., Yeung A.C.M., Hui D.S.C., Chan P.K.S. Longitudinal cytokine profile in patients with mild to critical COVID-19. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.763292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.763292</ArticleId><ArticleId IdType="pmc">PMC8685399</ArticleId><ArticleId IdType="pubmed">34938289</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappelmann N., Dantzer R., Khandaker G.M. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology. 2021;131 doi: 10.1016/j.psyneuen.2021.105295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2021.105295</ArticleId><ArticleId IdType="pmc">PMC8172271</ArticleId><ArticleId IdType="pubmed">34119855</ArticleId></ArticleIdList></Reference><Reference><Citation>De Benedetti F., Prencipe G., Bracaglia C., Marasco E., Grom A.A. Targeting interferon-&#x3b3; in hyperinflammation: opportunities and challenges. Nat. Rev. Rheumatol. 2021;17:678&#x2013;691. doi: 10.1038/s41584-021-00694-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00694-z</ArticleId><ArticleId IdType="pubmed">34611329</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L., Hanson B., Orban Z., Lim P.H., Palacio N.M., Jain R., Clark J.R., Graham E.L., Liotta E.M., Penaloza-MacMaster P., Koralnik I.J. Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination. medRxiv Prepr. Serv. Heal. Sci. 2021 doi: 10.1101/2021.08.08.21261763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.08.08.21261763</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzeri E., Romagnani P. CXCR3-binding chemokines: novel multifunctional therapeutic targets. Curr. Drug Targets: Immune, Endocr. Metab. Disord. 2005;5:109&#x2013;118. doi: 10.2174/1568008053174723.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568008053174723</ArticleId><ArticleId IdType="pubmed">15777209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepennetier G., Hracsko Z., Unger M., Van Griensven M., Grummel V., Krumbholz M., Berthele A., Hemmer B., Kowarik M.C. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases. J. Neuroinflammation. 2019;16:219. doi: 10.1186/s12974-019-1601-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1601-6</ArticleId><ArticleId IdType="pmc">PMC6857241</ArticleId><ArticleId IdType="pubmed">31727097</ArticleId></ArticleIdList></Reference><Reference><Citation>Croen K.D. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 1993;91:2446&#x2013;2452. doi: 10.1172/JCI116479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI116479</ArticleId><ArticleId IdType="pmc">PMC443304</ArticleId><ArticleId IdType="pubmed">8390481</ArticleId></ArticleIdList></Reference><Reference><Citation>Karupiah G., Xie Q.W., Buller R.M., Nathan C., Duarte C., MacMicking J.D. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science. 1993;261:1445&#x2013;1448. doi: 10.1126/science.7690156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7690156</ArticleId><ArticleId IdType="pubmed">7690156</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004;75:163&#x2013;189. doi: 10.1189/jlb.0603252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0603252</ArticleId><ArticleId IdType="pubmed">14525967</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamper E.F., Chatzigeorgiou A., Tsimpoukidi O., Kamper M., Dalla C., Pitychoutis P.M., Papadopoulou-Daifoti Z. Sex differences in oxidant/antioxidant balance under a chronic mild stress regime. Physiol. Behav. 2009;98:215&#x2013;222. doi: 10.1016/j.physbeh.2009.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2009.05.011</ArticleId><ArticleId IdType="pubmed">19477190</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava N., Barthwal M.K., Dalal P.K., Agarwal A.K., Nag D., Seth P.K., Srimal R.C., Dikshit M. A study on nitric oxide, beta-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depression. J. Affect. Disord. 2002;72:45&#x2013;52. doi: 10.1016/s0165-0327(01)00421-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-0327(01)00421-9</ArticleId><ArticleId IdType="pubmed">12204316</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki E., Yagi G., Nakaki T., Kanba S., Asai M. Elevated plasma nitrate levels in depressive states. J. Affect. Disord. 2001;63:221&#x2013;224. doi: 10.1016/s0165-0327(00)00164-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-0327(00)00164-6</ArticleId><ArticleId IdType="pubmed">11246099</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegener G., Harvey B.H., Bonefeld B., M&#xfc;ller H.K., Volke V., Overstreet D.H., Elfving B. Increased stress-evoked nitric oxide signalling in the Flinders sensitive line (FSL) rat: a genetic animal model of depression. Int. J. Neuropsychopharmacol. 2010;13:461&#x2013;473. doi: 10.1017/S1461145709990241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1461145709990241</ArticleId><ArticleId IdType="pubmed">19627650</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Mello C., Swain M.G. Immune-to-Brain communication pathways in inflammation-associated sickness and depression. Curr. Top. Behav. Neurosci. 2017;31:73&#x2013;94. doi: 10.1007/7854_2016_37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/7854_2016_37</ArticleId><ArticleId IdType="pubmed">27677781</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Kyuho, Park S.H., Chen J., Qiao Y., Giannopoulou E., Berg K., Hanidu A., Li J., Nabozny G., Kang Keunsoo, Park-Min K.-H., Ivashkiv L.B. Interferon-&#x3b3; represses M2 gene expression in human macrophages by disassembling enhancers bound by the transcription factor MAF. Immunity. 2017;47:235&#x2013;250.e4. doi: 10.1016/j.immuni.2017.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.07.017</ArticleId><ArticleId IdType="pmc">PMC5568089</ArticleId><ArticleId IdType="pubmed">28813657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Zhang S., Jeon R., Vuckovic I., Jiang X., Lerman A., Folmes C.D., Dzeja P.D., Herrmann J. Interferon gamma induces reversible metabolic reprogramming of M1 macrophages to sustain cell viability and pro-inflammatory activity. EBioMedicine. 2018;30:303&#x2013;316. doi: 10.1016/j.ebiom.2018.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.02.009</ArticleId><ArticleId IdType="pmc">PMC5953001</ArticleId><ArticleId IdType="pubmed">29463472</ArticleId></ArticleIdList></Reference><Reference><Citation>Burlacu R., Umlauf A., Marcotte T.D., Soontornniyomkij B., Diaconu C.C., Bulacu-Talnariu A., Temereanca A., Ruta S.M., Letendre S., Ene L., Achim C.L. Plasma CXCL10 correlates with HAND in HIV-infected women. J. Neurovirol. 2020;26:23&#x2013;31. doi: 10.1007/s13365-019-00785-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-019-00785-4</ArticleId><ArticleId IdType="pmc">PMC7018596</ArticleId><ArticleId IdType="pubmed">31414350</ArticleId></ArticleIdList></Reference><Reference><Citation>Huckans M., Fuller B.E., Olavarria H., Sasaki A.W., Chang M., Flora K.D., Kolessar M., Kriz D., Anderson J.R., Vandenbark A.A., Loftis J.M. Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection. Brain Behav. 2014;4 doi: 10.1002/brb3.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.200</ArticleId><ArticleId IdType="pmc">PMC3967530</ArticleId><ArticleId IdType="pubmed">24683507</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y. Indoleamine 2,3-dioxygenase--a new antioxidant enzyme. Mater. Med. Pol. 1989;21:244&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">2491278</ArticleId></ArticleIdList></Reference><Reference><Citation>Loftis J.M., Turner E.H. Novel treatment strategies for depression in patients with hepatitis C. Psychosomatics. 2010;51 doi: 10.1176/appi.psy.51.4.357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.51.4.357</ArticleId><ArticleId IdType="pubmed">20587769</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zt&#xfc;rk M., Yal&#x131;n Sapmaz &#x15e;., Kandemir H., Taneli F., Aydemir &#xd6;. The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder. Int. J. Clin. Pract. 2021;75 doi: 10.1111/ijcp.13739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13739</ArticleId><ArticleId IdType="pubmed">32997876</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner E.H., Loftis J.M., Blackwell A.D. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol. Ther. 2006;109 doi: 10.1016/j.pharmthera.2005.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2005.06.004</ArticleId><ArticleId IdType="pubmed">16023217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorkiewicz P., Waszkiewicz N. Biomarkers of post-COVID depression. J. Clin. Med. 2021;10 doi: 10.3390/jcm10184142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184142</ArticleId><ArticleId IdType="pmc">PMC8470902</ArticleId><ArticleId IdType="pubmed">34575258</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark S.M., Pocivavsek A., Nicholson J.D., Notarangelo F.M., Langenberg P., McMahon R.P., Kleinman J.E., Hyde T.M., Stiller J., Postolache T.T., Schwarcz R., Tonelli L.H. Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals. J. Psychiatry Neurosci. 2016;41:386&#x2013;394. doi: 10.1503/jpn.150226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/jpn.150226</ArticleId><ArticleId IdType="pmc">PMC5082509</ArticleId><ArticleId IdType="pubmed">27070351</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyes M.P., Saito K., Markey S.P. Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 1992;283(Pt 3):633&#x2013;635. doi: 10.1042/bj2830633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj2830633</ArticleId><ArticleId IdType="pmc">PMC1130930</ArticleId><ArticleId IdType="pubmed">1534219</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M., Chroscicki P., Swatler J., Stepnik D., De Biasi S., Hampel M., Brewinska-Olchowik M., Maliszewska A., Sklinda K., Durlik M., Wierzba W., Cossarizza A., Piwocka K. Remodeling of T Cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection. Front. Immunol. 2022;13 doi: 10.3389/fimmu.2022.886431.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rster C., Colombo M.G., Wetzel A.-J., Martus P., Joos S. Persisting symptoms after COVID-19. Dtsch. Arztebl. Int. 2022;119:167&#x2013;174. doi: 10.3238/arztebl.m2022.0147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0147</ArticleId><ArticleId IdType="pmc">PMC9215272</ArticleId><ArticleId IdType="pubmed">35236547</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mello A.J., Moretti M., Rodrigues A.L.S. SARS-CoV-2 consequences for mental health: neuroinflammatory pathways linking COVID-19 to anxiety and depression. World J. psychiatry. 2022;12:874&#x2013;883. doi: 10.5498/wjp.v12.i7.874.</Citation><ArticleIdList><ArticleId IdType="doi">10.5498/wjp.v12.i7.874</ArticleId><ArticleId IdType="pmc">PMC9331446</ArticleId><ArticleId IdType="pubmed">36051596</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirley K., Loftis J.M. A spotlight on HCV and SARS-CoV-2 co-infection and brain function. Pharmacol. Biochem. Behav. 2022;217 doi: 10.1016/j.pbb.2022.173403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbb.2022.173403</ArticleId><ArticleId IdType="pmc">PMC9088049</ArticleId><ArticleId IdType="pubmed">35561837</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>